On the Consequences of Poorly Defined Breakpoints for Rifampin Susceptibility Testing of Mycobacterium tuberculosis Complex
Claudio U. Köser, Sophia B. Georghiou, Thomas Schön, Max Salfinger
Abstract
, Shea et al. (J Clin Microbiol 59:e01885-20, 2021, https://doi.org/10.1128/JCM.01885-20) provide evidence that the CC endorsed by the Clinical and Laboratory Standards Institute for the Sensititre MYCOTB system, which is not FDA approved but is CE-IVD marked in the European Union, is likely also too high. These findings underscore the importance of calibrating AST methods against a rigorously defined reference standard, as recently proposed by the European Committee on Antimicrobial Susceptibility Testing, as well as the value of routine next-generation sequencing for investigating discordant AST results.
Topics & Concepts
rpoBMycobacterium tuberculosisFood and drug administrationDe factoMedicineClinical microbiologyTuberculosisMycobacterium tuberculosis complexConfusionMicrobiologyBiologyPharmacologyPathologyPolitical scienceLawPsychoanalysisPsychologyTuberculosis Research and EpidemiologyMycobacterium research and diagnosisAntibiotic Resistance in Bacteria